Log In
BCIQ
Print this Print this
 

MAP kinase kinase 2 (MAP2K2) (MEK2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting MAP kinase kinase 2 (MAP2K2) (MEK2)

BCIQ
Print ChartPrint this
2 - Cancer 3 - Cancer 1 - Cancer 2 - Cancer 1 - Cancer
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIMarketed
Cancer

1

2

1

3

2




 Products Targeting MAP kinase kinase 2 (MAP2K2) (MEK2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$17,034.0M

$14,800.0M

$2,234.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/28/2014

$17,034.0M

$14,800.0M

$2,234.0M

12/20/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury Trial today